Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.46 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 2/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.44 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1123593 | 0.94 | NR4A1 (0.48) | NR4A1NR4A2NR4A3F10LPAR1 | |
| SCHEMBL1122881 | 0.89 | LPAR1 (0.45) | F10LPAR1HDAC1HDAC6SLC2A1 | |
| SCHEMBL1123465 | 0.89 | SLC2A1 (0.51) | F10LPAR1HDAC1HDAC6SLC2A1 | |
| SCHEMBL1123244 | 0.88 | LPAR1 (0.52) | F10LPAR1SLC2A1MEP1BPPARG | |
| SCHEMBL1122783 | 0.87 | NR4A1 (0.49) | NR4A1NR4A2NR4A3F10LPAR1 | |
| SCHEMBL1123052 | 0.85 | NR4A1 (0.45) | NR4A1NR4A2NR4A3F10LPAR1 | |
| SCHEMBL1122385 | 0.82 | PPARG (0.47) | F10LPAR1HDAC1HDAC6SLC2A1 | |
| SCHEMBL1123395 | 0.82 | F10 (0.51) | NR4A2F10LPAR1HDAC1HDAC6 | |
| SCHEMBL1122959 | 0.82 | LPAR1 (0.54) | LPAR1HDAC1HDAC6SLC2A1 | |
| SCHEMBL1122692 | 0.81 | LPAR1 (0.55) | LPAR1HDAC1HDAC6SLC2A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1644321-B1 | NEW BENZAMIDES AS PPATY MODULATORS | S A L V A T LAB SA (ES) | 2011-02-09 | — | — | EP | disclosed |
| US-20060160894-A1 | Benzamides as ppar modulators | LABORATORIOS S.A.L.V.A.T.,S.A. (ES) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | PPARD, PPARA, PPARG | NR4A1 46/4885NR4A2 66/4885NR4A3 88/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.